Arrail Group Past Earnings Performance
Past criteria checks 0/6
Arrail Group's earnings have been declining at an average annual rate of -32%, while the Healthcare industry saw earnings growing at 15.3% annually. Revenues have been growing at an average rate of 15.7% per year.
Key information
-32.0%
Earnings growth rate
-30.8%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 15.7% |
| Return on equity | -43.2% |
| Net Margin | -43.2% |
| Last Earnings Update | 31 Mar 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Arrail Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 22 | 1,624 | -701 | 356 | 33 |
| 30 Sep 21 | 1,636 | -878 | 244 | 29 |
| 30 Jun 21 | 1,576 | -739 | 228 | 28 |
| 31 Mar 21 | 1,515 | -599 | 212 | 27 |
| 31 Mar 20 | 1,100 | -317 | 202 | 27 |
| 31 Mar 19 | 1,080 | -301 | 211 | 19 |
Quality Earnings: I1D is currently unprofitable.
Growing Profit Margin: I1D is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if I1D's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare I1D's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: I1D is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.1%).
Return on Equity
High ROE: I1D has a negative Return on Equity (-43.24%), as it is currently unprofitable.